Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CLCA4 antisense RNA 1 (CLCA4-AS1) is a long non-coding RNA transcribed antisense to the CLCA4 gene. Its primary molecular function is likely to regulate CLCA4 expression, possibly affecting transcriptional and post-transcriptional control of CLCA4. As CLCA4 acts as a tumor suppressor and plays a role in epithelial differentiation, the regulation by CLCA4-AS1 could have indirect but biologically significant effects on cancer biology. However, specific functions, interaction partners, and therapeutic relevance of CLCA4-AS1 itself remain poorly characterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CLCA4 antisense RNA 1 (CLCA4-AS1).